Metastatic colorectal cancer (mCRC)

Metastatic colorectal cancer (mCRC) occurs when the cancer cells have spread from the place where it has started (colon or rectum) to other parts of the body.

Showing all 6 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
1
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
PlGF
,
VEGF-A
,
VEGF-B
Fusion protein
Zaltrap®
25 mg/mL
2 mg
tba
tba
197,00 
view product
Max:
Min: 11
Step: 1
VEGF-A
Monoclonal Antibody
Zirabev®
25 mg/mL
2 mg
tba
tba
200,00 
view product
Max: 50
Min: 11
Step: 1
VEGF-A
Monoclonal Antibody
Alymsys®
25 mg/mL
2 mg
tba
tba
197,00 
view product
Max: 50
Min: 11
Step: 1
VEGF-A
Monoclonal Antibody
Aybintio®
25 mg/mL
2 mg
tba
tba
197,00 
view product
Max: 50
Min: 11
Step: 1
VEGF-A
Monoclonal Antibody
Abevmy®
25 mg/mL
2 mg
tba
tba
207,00 
view product
Max: 50
Min: 11
Step: 1
VEGF-A
Monoclonal Antibody
Vegzelma®
25 mg/mL
2 mg
tba
tba
198,00 
view product
Max: 50
Min: 11
Step: 1

Not looking for Metastatic colorectal cancer (mCRC)?

Search our therapeutic molecules product database